세계의 당뇨병성 족부궤양 시장 보고서(2025년)
Diabetic Foot Ulcer Global Market Report 2025
상품코드 : 1824640
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

당뇨병성 족부궤양 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.5%를 나타내 83억 6,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 맞춤형 의료, 원격 의료 및 원격 모니터링, 신흥 시장 확대, 첨단 생체 재료로 인한 것입니다. 예측 기간의 주요 동향으로는 디지털 건강 솔루션, 환자 중심 케어, 공동 케어 모델, 예방 케어, 교육 등이 있습니다.

향후 5년간의 성장률 7.5%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역마찰은 독일과 이탈리아에서 개발된 생물활성 드레싱재료와 음압상처치료 시스템의 가격을 상승시켜 궤양치유 지연과 절단예방비용 상승을 초래하여 미국의 발병치료에 지장을 초래할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

당뇨병성 족부궤양 시장의 예상 성장은 노년 인구 증가에 의해 촉진됩니다. 노년 인구는 일반적으로 65세 이상의 노인층을 의미합니다. 당뇨병성 족부궤양은 노인층에서 만연하여 큰 문제가 되고 있습니다. 당뇨병을 앓고 있는 노인들은 신경장애, 혈행장애, 치유 과정의 지연 등의 요인으로 인해 특히 족부궤양이 발생하기 쉽습니다. 예를 들어 2022년 10월에 세계보건기구(WHO)가 보고한 것처럼 2030년까지 전 세계적으로 6명 중 1명이 60세 이상의 노인이 될 것으로 예측됩니다. 게다가 2050년까지 이 연령대는 두배로 늘어나 21억 명에 달할 것으로 예상됩니다. 그 결과 노인 인구 증가가 당뇨병성 족부궤양 시장 성장의 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Diabetic foot ulcers are open sores or wounds that frequently develop on the feet of individuals living with diabetes. These ulcers represent a severe and often persistent complication of diabetes, largely attributed to the detrimental impact of the disease on the circulatory and nervous systems. The treatment of diabetic foot ulcers focuses on improving blood sugar control and implementing vascular therapies.

Diabetic foot ulcers encompass three primary categories including advanced wound care dressings, biologics, and therapy devices. Advanced wound care dressings are specialized medical dressings designed to facilitate the healing of complex or chronic wounds, including neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers. These treatments are typically administered in healthcare settings such as hospitals, ambulatory surgery centers, and home care services.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diabetic foot ulcer market research report is one of a series of new reports from The Business Research Company that provides diabetic foot ulcer market statistics, including diabetic foot ulcer industry global market size, regional shares, competitors with a diabetic foot ulcer market share, detailed diabetic foot ulcer market segments, market trends and opportunities and any further data you may need to thrive in the diabetic foot ulcer industry. This diabetic foot ulcer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diabetic foot ulcer market size has grown strongly in recent years. It will grow from $5.84 billion in 2024 to $6.26 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing diabetes prevalence, aging population, improvements in wound care technologies, healthcare access and awareness.

The diabetic foot ulcer market size is expected to see strong growth in the next few years. It will grow to $8.36 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote monitoring, emerging markets expansion, advanced biomaterials. Major trends in the forecast period include digital health solutions, patient-centred care, collaborative care models, preventive care and education.

The forecast of 7.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. podiatric care by inflating prices of bioactive dressings and negative pressure wound therapy systems developed in Germany and Italy, resulting in delayed ulcer healing and higher amputation prevention costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The diabetic foot ulcer market's anticipated growth is set to be propelled by the increasing geriatric population. The term 'geriatric population' encompasses the elderly segment, typically aged 65 and older. Diabetic foot ulcers present a prevalent and substantial concern within the senior demographic. Elderly individuals living with diabetes are particularly vulnerable to developing foot ulcers due to factors such as neuropathy, diminished circulation, and slower healing processes. As an illustration, as reported by the World Health Organization in October 2022, it is projected that globally, by 2030, 1 in 6 individuals will belong to the 60 and older age group. Furthermore, by 2050, this age group is expected to double in size, reaching 2.1 billion individuals. Consequently, the increasing geriatric population serves as a driving force behind the growth of the diabetic foot ulcer market.

The escalating adoption of telehealth is poised to contribute to the growth of the diabetic foot ulcer market. Telehealth, denoting the delivery and facilitation of healthcare services and related services via remote telecommunications technology, plays a pivotal role in the management of diabetic foot ulcers. These services are utilized for monitoring foot ulcers and providing essential follow-up care. For instance, findings from a study involving 1,769 older adults conducted by the Michigan Population Studies Center in December 2022 revealed a 5.59% increase in the utilization of telehealth for email and portal messages, along with a substantial 19.99% rise in video chats with healthcare professionals among older individuals. Therefore, the increasing adoption of telehealth contributes to the growth of the diabetic foot ulcer market.

A significant impediment to the diabetic foot ulcer market is the substantial expense associated with medication and care. The elevated cost of treatment encompasses increased healthcare service expenses, encompassing medical examinations, therapies, and medical procedures. This elevated cost can pose a considerable hindrance to treatment access for numerous patients, particularly those lacking sufficient insurance coverage. As an illustration, a report from the National Library of Medicine in July 2023 unveiled that the comprehensive medical expenditure for managing diabetic foot disease in the United States ranges from $9 to $13 billion. This data underscores the substantial financial burden associated with diabetic foot ulcer treatment. Consequently, the high treatment cost hinders the expansion of the diabetic foot ulcer market.

Leading companies within the diabetic foot ulcer market are committed to the development of innovative products tailored to the requirements of their existing clientele. These cutting-edge solutions, such as Theruptor Novo, are designed to enhance the management of diabetic foot ulcers, focusing on wound care, monitoring, and overall foot health. For instance, in October 2022, Healthium Medtech Limited, an Indian medical devices company, introduced Theruptor Novo-an innovative device designed for diabetic foot ulcer treatment. This non-invasive, minimally invasive device employs focused ultrasound to establish microchannels in the skin and surrounding tissue, facilitating the delivery of oxygen and nutrients to the ulcer site, thus promoting the healing process. Additionally, it holds the potential to aid patients in ulcer healing and mitigating the need for amputation.

In March 2022, Convatec Group PLC, a UK-based company specializing in medical products and technologies, completed the acquisition of Triad Life Sciences Inc. The objective behind this acquisition is to fortify Convatec Group plc's position in the wound care sector, venture into the rapidly expanding wound biologics segment, and accelerate the development and commercialization of new product offerings. Triad Life Sciences Inc., a U.S.-based biotechnology firm, specializes in the development of products for the treatment of diabetic foot ulcers.

Major companies operating in the diabetic foot ulcer market are Cardinal Health Inc., Johnson And Johnson Private Limited, 3M Company, Medtronic PLC, Medline Industries Inc., Coloplast A/S, B. Braun Melsungen AG, Nitto Denko Corporation, Smith and Nephew PLC, Human Biosciences Inc., Derma Sciences Inc., Convatec Inc., Molnlycke Health Care AB., Integra LifeSciences Corporation, Lohmann And Rauscher International GmbH and Co. KG, Acelity L.P. Inc., Pliant Therapeutics Inc., MiMedx Group, BSN Medical GMBH, Osiris Therapeutics Inc., Advanced Medical Solutions Group PLC, Organogenesis Inc., Healiance Inc., Misonix Inc., MediWound Ltd., Tissue Regenix Group Limited, Systagenix Wound Management Limited, Healios KK.

North America was the largest region in the diabetic foot ulcer market in 2024. The regions covered in diabetic foot ulcer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetic foot ulcer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetic Foot Ulcer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetic foot ulcer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for diabetic foot ulcer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetic foot ulcer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Diabetic Foot Ulcer Market Characteristics

3. Diabetic Foot Ulcer Market Trends And Strategies

4. Diabetic Foot Ulcer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Diabetic Foot Ulcer Growth Analysis And Strategic Analysis Framework

6. Diabetic Foot Ulcer Market Segmentation

7. Diabetic Foot Ulcer Market Regional And Country Analysis

8. Asia-Pacific Diabetic Foot Ulcer Market

9. China Diabetic Foot Ulcer Market

10. India Diabetic Foot Ulcer Market

11. Japan Diabetic Foot Ulcer Market

12. Australia Diabetic Foot Ulcer Market

13. Indonesia Diabetic Foot Ulcer Market

14. South Korea Diabetic Foot Ulcer Market

15. Western Europe Diabetic Foot Ulcer Market

16. UK Diabetic Foot Ulcer Market

17. Germany Diabetic Foot Ulcer Market

18. France Diabetic Foot Ulcer Market

19. Italy Diabetic Foot Ulcer Market

20. Spain Diabetic Foot Ulcer Market

21. Eastern Europe Diabetic Foot Ulcer Market

22. Russia Diabetic Foot Ulcer Market

23. North America Diabetic Foot Ulcer Market

24. USA Diabetic Foot Ulcer Market

25. Canada Diabetic Foot Ulcer Market

26. South America Diabetic Foot Ulcer Market

27. Brazil Diabetic Foot Ulcer Market

28. Middle East Diabetic Foot Ulcer Market

29. Africa Diabetic Foot Ulcer Market

30. Diabetic Foot Ulcer Market Competitive Landscape And Company Profiles

31. Diabetic Foot Ulcer Market Other Major And Innovative Companies

32. Global Diabetic Foot Ulcer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetic Foot Ulcer Market

34. Recent Developments In The Diabetic Foot Ulcer Market

35. Diabetic Foot Ulcer Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기